Estrogen Therapy (ET) may protect against age-related cognitive decline and neuropsychiatric disorders (e.g. Alzheimer's disease). The biological basis for this putative neuroprotective effect is not fully understood, but may include modulation of cholinergic systems. Cholinergic dysfunction has been implicated in age-related memory impairment and Alzheimer's disease. However, to date no one has investigated the effect of long-term ET on brain cholinergic muscarinic receptor aging, and relate...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Estrogen therapy and brain muscarinic receptor density in healthy females: a SPET study.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record